Faster ANDA Approval

  • 6:49
  • Published On: March 20, 2015
Cinema View
Embed
In an interaction with NDTV Profit, Kewal Handa, former MD of Pfizer, said that if USFDA adopts incentive-based policy in India, it will lead to faster-than-expected approval of drugs for companies.

Related Videos

Moderna Sues Pfizer Over Covid Vaccine
August 26, 2022 0:50
"Pfizer's Covid Pill Has Potential To Be Game-Changer": Top Virologist To NDTV
November 16, 2021 9:01
Will Generic Anti-Covid Pills Redefine The Fight Against The Pandemic?
November 16, 2021 33:03
Pfizer Agrees To Let Others Make Its Covid Pill: What It Means For India
November 16, 2021 14:14
Pfizer To Allow Other Companies To Produce Its Covid Pill
November 16, 2021 3:00
"Not Even Enough For...": Vaccine Panel Chief On Pfizer, Moderna Offers
August 03, 2021 4:44
Pfizer In "Final Stages" Of Approval For Covid Vaccine In India: CEO
June 23, 2021 5:20
Different Booster Shots The Way Forward?
June 23, 2021 7:15
The Biggest Stories Of June 04, 2021
June 04, 2021 17:19
For Delta Variant, Need Shorter Gap Between Vaccine Doses: Lancet Study
June 04, 2021 2:47
Should All Covid Vaccine Makers Be Granted Indemnity?
June 03, 2021 24:47
Top News Of The Day: Foreign Vaccines A Step Closer With Key Waivers
June 02, 2021 21:58
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination